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ABSTRACT
Retinitis pigmentosa (RP) is a rare genetic disease that causes gradual blindness through retinal degeneration. Intriguingly, seven of
the 24 genes identified as responsible for the autosomal-dominant form (adRP) are ubiquitous spliceosome components whose
impairment causes disease only in the retina. The fact that these proteins are essential in all organisms hampers genetic,
genomic, and physiological studies, but we addressed these difficulties by using RNAi in Caenorhabditis elegans. Our study of
worm phenotypes produced by RNAi of splicing-related adRP (s-adRP) genes functionally distinguishes between components
of U4 and U5 snRNP complexes, because knockdown of U5 proteins produces a stronger phenotype. RNA-seq analyses of
worms where s-adRP genes were partially inactivated by RNAi, revealed mild intron retention in developing animals but not in
adults, suggesting a positive correlation between intron retention and transcriptional activity. Interestingly, RNAi of s-adRP
genes produces an increase in the expression of atl-1 (homolog of human ATR), which is normally activated in response to
replicative stress and certain DNA-damaging agents. The up-regulation of atl-1 correlates with the ectopic expression of the
pro-apoptotic gene egl-1 and apoptosis in hypodermal cells, which produce the cuticle, but not in other cell types. Our model
in C. elegans resembles s-adRP in two aspects: The phenotype caused by global knockdown of s-adRP genes is cell type-
specific and associated with high transcriptional activity. Finally, along with a reduced production of mature transcripts, we
propose a model in which the retina-specific cell death in s-adRP patients can be induced through genomic instability.
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INTRODUCTION
Retinitis pigmentosa (RP) is a rare disease that affects approx-
imately one out of 4000 individuals (more than 1.5 million
people worldwide). RP causes a progressive loss of vision
and ultimately blindness. Patients affected by this disease
present defects in photoreceptors (rods and cones) and
RPE (retinal pigment epithelium) cells that trigger cellular
apoptosis and degeneration of the retina (Hartong et al.
2006; Ferrari et al. 2011). Although sporadic RP is not rare,
most RP patients present inherited mutations, through
diverse modes of genetic transmission, in any of the 50 genes
that have been related to the disease (Daiger et al. 2013). Of
all these RP familial cases, 30%–40% show autosomal-dom-
inant genetic inheritance (Hartong et al. 2006). To date, mu-
tations in 24 genes have been linked to autosomal-dominant
RP (adRP) (Rossmiller et al. 2012). Among these genes, seven
(PRPF3, PRPF4, PRPF6, PRPF8, PRPF31, SNRNP200/BRR2,
and RP9) are coding for ubiquitous components of the spli-
ceosome machinery and, when defective, cause disease only
in the retina (Mordes et al. 2006; Zhao et al. 2009; Tanackovic
et al. 2011b; Chen et al. 2014). All of them but RP9/PAP-1,
which interacts at the protein level with PRPF3, are evolu-
tionarily conserved (Supplemental Fig. S1; Maita et al. 2005).
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A better understanding of the mechanisms of action of
these genes will provide a new insight into the disease that
could help in the search of potential therapies for adRP pa-
tients. However, the essential function of s-adRP genes limits
genetic and cellular studies. As a consequence, most of the
knowledge that we have about how the spliceosome works
comes from biochemical or in vitro studies. Themulticellular
organism Caenorhabditis elegans, thanks to the extraordinary
conservation of these splicing-related proteins through evo-
lution, offers a shortcut to understand why a mild reduction
in the activity of genes required in all cells is critical only for a
specific tissue.
The spliceosome is probably the most complex molecular
machine of the cell and most of its components are evolu-
tionarily conserved (Fabrizio et al. 2009). Moreover, splicing
mechanisms are also similar from yeast to humans (Wahl
et al. 2009; Will and Lührmann 2011). More than 200 pro-
teins form this macromolecular complex that removes
introns from eukaryotic pre-mRNAs. This is a highly dynam-
ic process, with proteins going in and out of the complex de-
pending on the splicing step that is taking place. The core of
the spliceosome is composed of small nuclear ribonucleopro-
teins (snRNPs), which are complexes of proteins and uri-
dine-rich small nuclear RNAs (named U1, U2, U4, U5, and
U6 snRNAs). Particularly, the splicing-related genes linked
with adRP encode proteins present in the U4/U6·U5 tri-
snRNP complex, which is a main actor in the process of splic-
ing. Among these proteins, PRP3, PRP4, and PRP31 are U4
snRNP components, whereas SNRNP200/BRR2, PRP6, and
PRP8 are part of the U5 snRNP (Maita et al. 2005; Liu
et al. 2006). For the sake of simplicity, we can place the s-
adRP proteins within the process of splicing as follows: An
intron flanked by two exons is recognized by the pre-spliceo-
some (U1 and U2 snRNPs complexes). Next, the U4/U6·U5
tri-snRNP remodels the spliceosome to later exclude U1 and
U4 snRNPs, and keep U2, U5, and U6 snRNPs to form the
activated spliceosome. Then, two catalytic steps occur to re-
move the intron and join the flanking exons.
In the present study, we use genetic and genomic tools to
investigate in a multicellular organism how the alteration of a
common and essential process such as pre-mRNA matura-
tion can affect specific cells only.
RESULTS
A C. elegans toolkit to study splicing-related autosomal-
dominant retinitis pigmentosa (s-adRP): RNAi, mutants,
and transgenic animals
Despite the genetic nature of s-adRP, development of animal
models to study this disorder has been hampered by the es-
sential functions of the genes whose mutations are responsi-
ble of the disease. In multicellular organisms, complete
depletion of s-adRP genes leads to lethality and, in conse-
quence, described mutations in splicing-related genes caus-
ing adRP are either partial-loss-of-function mutations or
deletion alleles that cause haploinsufficiency. To mimic and
study the effect of this mild impairment of gene functions
in C. elegans we took advantage of RNA interference (RNAi).
RNAi was first discovered and developed as a research tool
in C. elegans (Fire et al. 1998). RNAi in this nematode is
systemic, which implies that the effect of a specific dsRNA
spreads through the whole organism. BecauseC. elegans feeds
on bacteria, the feeding of worms with a clone producing a
gene-specific RNAi results in the delivery of the specific
dsRNA into the animal cells. As a complementary RNAi tech-
nique, dsRNA can also be administered by microinjection
into the worm germline, which normally produces a stronger
phenotype. RNAi clones corresponding to s-adRP genes were
obtained, and validated by sequencing, from the two existing
C. elegans RNAi libraries (Kamath et al. 2003; Rual et al.
2004), with the exception of the RNAi clone for snrp-200,
which was generated in our laboratory by Gateway cloning
(Fig. 1A). By quantitative PCR we investigated the effective-
ness of the RNAi for some s-adRP genes and found that
>50% of the targeted transcripts were depleted in our
RNAi conditions (Fig. 1B).
Haploinsufficiency in s-adRP has been reported for hu-
man PRPF31 but not for PRPF8, which does not allow the
full loss of one copy of the gene (Abu-Safieh et al. 2006).
We investigated haploinsufficiency in C. elegans by using
deletion alleles for prp-31 and prp-8. One copy of prp-31
(gk1094) or prp-8(gk3511) alleles (The C. elegans Deletion
Mutant Consortium 2012), balanced with the translocation
hT2 or with classic genetic markers, did not produce haploin-
sufficiency in terms of fertility or embryonic lethality
(Supplemental Fig. S2A).
We further explored other evidences of haploinsufficiency
in worms carrying the prp-31 deletion by investigating
different penetrance among individuals. We monitored the
progeny of prp-31(gk1094) heterozygous individuals and ob-
served no inter-individual variability in terms of brood size
(Supplemental Fig. S2B). Moreover, the Mendelian propor-
tions in the offspring of heterozygous animals were normal,
with approximately one-quarter of arrested larvae (prp-31
(gk1094) homozygous) (Supplemental Fig. S2C).
In conclusion, prp-31(gk1094) and prp-8(gk3511) are hap-
losufficient in terms of somatic and germline development,
although we cannot discard haploinsufficiency in any other
specific cellular process. Strains carrying these mutations
could be useful to screen for enhancers and therefore for po-
tential modifiers of the disease.
Finally, we studied the expression of s-adRP genes using
transgenic reporter strains. We analyzed the expression pat-
tern of a prp-8 transcriptional reporter (Pprp-8::GFP) and
observed an ubiquitous expression (Fig. 1C; Hunt-
Newbury et al. 2007). This transgene, although informative,
did not contain all the regulatory regions of the gene and
moreover was not integrated in the worm genome, resulting
in mosaicism in its expression. Thus, we made several
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attempts to express s-adRP proteins tagged with green fluo-
rescent protein (GFP), but we were not able to obtain trans-
genic animals by these means, suggesting that ectopic
expression of these proteins could be toxic for animal devel-
opment. Alternatively, we generated a transcriptional report-
er containing the promoter region of prp-31 in framewith the
nuclear histone 2B, the GFP gene, and the 3′ UTR of prp-31.
Animals were transformed by gene bombardment or micro-
injection, and we obtained several strains carrying this
reporter either integrated in the genome or as an extrachro-
mosomal array. All these strains broadly expressed the trans-
genes along the animal providing a useful genetic background
to screen for other genes or small molecules capable of regu-
lating the expression levels of prp-31 (Fig. 1D).
In summary, RNAi clones for s-adRP genes, strains
carrying deletion alleles for prp-31 and prp-8 in heterozygos-
ity, and several GFP reporter strains for prp-31 constitute the
first version of a toolkit to investigate s-adRP genes in
C. elegans.
RNAi phenotypes of s-adRP genes encoding U5 snRNP
components are more dramatic than those
corresponding to U4 snRNP proteins
To study the RNAi phenotypes of prp-3, prp-4, prp-6, prp-8,
prp-31, and snrp-200, we performed RNAi by feeding in a
synchronized population of worms at the first larval stage
(L1) (Porta-de-la-Riva et al. 2012). We clearly distinguished
FIGURE 1. C. elegans toolkit to study s-adRP. (A) Scheme of s-adRP genes in C. elegans including the regions that are targeted by RNAi clones (black
bars), the deleted fragment in the prp-31(gk1094) and prp-8(gk3511) alleles (red bars), and the elements of the prp-8 and prp-31 reporters generated in
this study (green rectangles). The prp-31(gk1094) allele consists of a 5-bp insertion/1953-bp deletion. prp-8(gk3511) is a 1823-bp deletion. (B)
Quantification of prp genes’ expression levels after their respective inactivation by RNAi. mRNA levels of prp genes are represented relative to the
expression in gfp(RNAi) control animals (arbitrary value of 1, indicated with a red line). Transcript levels are normalized against tbb-2 levels in
each case. RNA for analysis was obtained from up to four biological replicates (n). RNA from samples used for RNA-seq analyses were included.
Error bars represent standard error of the mean. (C) Representative confocal image showing a transgenic worm expressing the transgene
sEx12486, which consists of the GFP under the control of a promoter region for prp-8. (D) Representative confocal image showing a transgenic
worm expressing the transgene cerEx79, which consists of the fusion protein GFP::H2B under the control of prp-31 promoter and 3′UTR.
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two phenotypic groups: Whereas prp-6, prp-8 and snrp-200
RNAi produced larval arrest, animals treated with RNAi for
prp-3, prp-4, and prp-31 produced adult animals that were
sterile (Table 1; Fig. 2A).
As mentioned in the introduction, all six proteins are com-
ponents of the U4/U6·U5 tri-snRNP, but only PRP-6, PRP-8
and SNRP-200 are present in the U5 snRNP and participate
in the activated spliceosome (Fig. 2B). This functional differ-
ence could explain the stronger phenotype caused by their
corresponding RNAi feeding clones.
To increase the efficiency of the RNAi, we synthesized and
microinjected dsRNA for prp-3, prp-4, and prp-31. These
RNAi by injection caused embryonic lethality for all three,
confirming the phenotype observed for all the s-adRP genes
in a previous large-scale RNAi by injection study (Sönnich-
sen et al. 2005).
Therefore, a strong RNAi inactivation of s-adRP genes
produces a nonviable phenotype. However, RNAi by feeding
of s-adRP genes produces milder defects, with prp-6, prp-8,
and snrp-200 displaying more dramatic RNAi phenotypes
probably because of their functions in the activated or catalyt-
ic spliceosome.
The imprint of s-adRP genes on splicing catalysis
To study the molecular consequences of a partial inactivation
of s-adRP genes, we analyzed the transcriptomes of animals
treated with RNAi against prp-6, prp-8, and prp-31. L1 ani-
mals were fed with the corresponding RNAi clone and har-
vested after 24 h at 20°C, before developmental alterations
due to RNAi became perceptible. In order to estimate the
global levels of intron retention, we quantified the proportion
of reads (read length 73 bp)mapping in intronic sequences in
experimental and control samples. To ensure that our analy-
sis was detecting intron retention and not stabilization of ex-
cised introns, we scored the proportion of reads mapping
within introns and reads mapping in exon–intron junctions
(Fig. 3A). Mild intron retention levels were observed in ani-
mals treated with RNAi against these three s-adRP genes. The
strongest levels of intron retention were detected in prp-8
(RNAi) samples. More precisely, 6.49% and 4.07% of the
reads mapped in exon–intron junctions in prp-8(RNAi)
and gfp(RNAi) animals, respectively. These results indicate
a basal level of unspliced transcripts in control animals, sug-
gesting that the splicing machinery is not 100% efficient in
the excision of introns in normal conditions. We corroborat-
ed the increase of intron retention events in prp-8(RNAi) an-
imals by semiquantitative RT-PCR (Supplemental Fig. S3A)
and by detecting reads crossing the exon–intron border of
some pre-mRNAs (Supplemental Fig. S3B).
By considering only RNA-seq reads that mapped in anno-
tated introns, we identified 69 statistically significant (P-val-
ue≤ 0.01) common intron retention events in the whole
genome of L3 animals treated with RNAi against s-adRP
genes (Supplemental Table S1). We did not detect any com-
mon characteristic of the retained introns in terms of length
(ranging from 114 to 4506 bp) or position within the gene
(Supplemental Table S1).
The nonsense-mediated-decay (NMD) machinery pre-
vents the expression of truncated proteins by degrading tran-
scripts with premature termination codons (PTCs) (Hodgkin
et al. 1989; Chang et al. 2007). Previous transcriptomic stud-
ies estimated that 20% of C. elegans genes produce transcripts
that are degraded by the NMD pathway and many of those
transcripts arise from splicing errors as retention of introns
or wrong splice site selection (Ramani et al. 2009). Therefore,
in our RNAi experiments the NMD system could be masking
a stronger effect on intron retention. To address this concern
we performed the same transcriptomic studies in the NMD
defective strain smg-1(r861). Although the proportion of
reads on introns was slightly higher in all smg-1(r861) sam-
ples, results were comparable with those obtained in wild-
type animals and we did not observe a more dramatic effect
on intron retention in NMD mutants upon RNAi of s-adRP
genes (Fig. 3A).
Interestingly, in adult animals without a germline (5-d-old
glp-4(bn2) mutants) we did not observe the mild intron re-
tention associated with prp-8(RNAi), probably because of
the much more reduced levels of transcriptional activity in
adult animals compared with animals during development
(Fig. 3B).
RNAi of s-adRP genes induces the expression
of the pro-apoptotic factor egl-1 and apoptosis
in a cell type-specific manner
The transcriptome of prp-6(RNAi), prp-8(RNAi), and prp-31
(RNAi) animals compared with those exposed to control
RNAi brought to light a list of genes misregulated with dis-
tinct P-values derived from our bioinformatic analysis
(Supplemental Table S2). There are different strategies to
take benefit of this transcriptomic data but we followed a can-
didate-gene approach because among the genes with the low-
est P-value (≤0.0001) we found the effector of apoptosis
egl-1, which encodes a conserved BH3-only domain protein
TABLE 1. Phenotypes observed after RNAi of s-adRP genes by
two different methods
RNAi by feeding RNAi by injection
U4 protein coding genes
prp-3 Sterility Embryonic lethality
prp-4 Sterility Embryonic lethality
prp-31 Sterility Embryonic lethality
U5 protein coding genes
prp-6 Larval arrest Embryonic lethalitya
prp-8 Larval arrest Embryonic lethalitya
snrp-200 Larval arrest Embryonic lethalitya
aInformation obtained from the C. elegans PhenoBank
(Sönnichsen et al. 2005).
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(Conradt and Horvitz 1998; Nehme and Conradt 2008). We
validated this up-regulation by qPCR (Fig. 4A,B).
Because we analyzed the transcriptome of a multicellular
organism, we wondered whether the over-expression of egl-
1 was global or cell type-specific. Hence, we treated EGL-1::
GFP transgenic animals with prp-8(RNAi) and observed
GFP expression in somatic cells that are
not expected to suffer apoptosis in nor-
mal development (Sulston and Horvitz
1977). In wild-type worms, programmed
cell death occurs in 18 cells at the L2 stage
(Fig. 5A; Lettre and Hengartner 2006).
However, prp-8(RNAi) animals dis-
played ectopic EGL-1::GFP expression
that was particularly evident in hypoder-
mal seam cells, which form a row from
the head to the tail of the worm (Fig. 5B).
To confirm that ectopic egl-1 expres-
sion results in apoptosis, we looked for
apoptotic cell-corpses in larval cells using
the mutant strain ced-6(n2095), which is
defective in the clearance of apoptotic
cells. As expected, we detected apoptotic
corpses in somatic hypodermal cells of
animals treated with prp-8(RNAi) that
were not present in wild-type worms
(Fig. 5C,D). Moreover, using a GFP re-
porter for hypodermal seam cells, we ob-
served a reduced number of seam cells
in prp-8(RNAi) worms (Supplemental
Fig. S4).
We further investigated this cell-spe-
cific phenotype by using strains where
the RNAi effect was tissue-specific.
These strains contain a mutation in the
rde-1 gene, which is essential for RNAi,
and ectopically express rde-1 either in
muscle or hypodermal cells only. Strik-
ingly, we observed the characteristic
growth arrest of prp-8(RNAi) when the
RNAi machinery was functional in hypo-
dermal cells, but we did not detect such
phenotype when the prp-8(RNAi)was ef-
fective in muscle cells (Fig. 6A,B).
Interestingly, these hypodermal cells syn-
thesize the proteins that form the cuticle
and, similarly to retinal cells, require
high transcriptional activity (Page and
Johnstone 2007).
atl-1, the homolog of human ATR,
is up-regulated after RNAi of s-adRP
genes
Following the candidate gene approach,
among the top up-regulated genes atl-1/ATR also called
our attention (Fig. 4A,B). ATM and ATR are the primary sen-
sors of DNA damage in humans. Whereas ATMmainly sens-
es DNA double-strand breaks (DSBs), ATR responds to other
DNA lesions such as those produced by replication fork stall-
ing or UV damage, and it is recruited together with
FIGURE 2. RNAi experiments classify s-adRP genes in two phenoclusters. (A) Developmental
growth in animals treated with RNAi for s-adRP genes. Body length of wild-type worms with
the indicated RNAi clones, starting from synchronized L1 and grown at 20°C. Mean body length
of 50 worms per RNAi condition was scored at the indicated time points. Animal length wasmea-
sured using the ImageJ software. Control worms were fed with the L4440 plasmid (empty vector).
(B) Simplified scheme of the role of s-adRP genes in the splicing process. The sixC. elegans s-adRP
proteins are part of the tri-snRNP U4/U6·U5 complex. After the formation of the activated spli-
ceosome, U5, but not U4, s-adRP proteins are required for subsequent splicing steps involving
transesterification reactions. Exons are linked by thinner rectangles that represent an intron.
White box: PRP-3, PRP-4, and PRP-31 are U4-specific, whereas PRP-6, PRP-8, and SNRNP-
200 are U5-specific.
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Replication protein A (RPA) to single-strand DNA regions
originated by DNA damage (Kastan and Bartek 2004; Falck
et al. 2005; Garcia-Muse and Boulton 2005).
Thus, we were persuaded to investigate whether a slight
defect in the spliceosome activity could produce DNA le-
sions. It has been described that inactivation of various
RNA processing factors induces the accumulation of DNA
damage foci (Montecucco and Biamonti 2013). Therefore,
we used the RPA-1::YFP reporter to study the effect of prp-
8(RNAi) on the foci formation of the DNA damage sensing
protein RPA-1. RPA-1::YFP is expressed in all worm cells,
but the distribution of this tagged protein is diffuse and
does not form visible foci (Vermezovic et al. 2012). We did
not observe RPA-1::GFP foci after prp-8(RNAi) in normal
growth conditions but the number of foci was higher in
prp-8(RNAi) worms than in control animals upon UV expo-
sure (Fig. 7). This result suggests that a partial depletion of
prp-8 activity may cause an alteration in the DNA that is
not reported by our RPA-1::YFP transgenic in normal condi-
tions, but it is uncovered upon UV exposure.
Another DNA insult that can increase the activity of atl-1 is
replicative stress. Replication forks can be collapsed by the
presence of R-loops (DNA–RNA hybrids), whose formation
can be promoted by alterations in the spliceosome (Aguilera
and García-Muse 2012; Hamperl and Cimprich 2014). Such
impact of R-loops on the replication machinery may induce
replicative stress (Mazouzi et al. 2014). To induce replicative
stress in C. elegans larvae, we exposed developing worms to
hydroxyurea and observed, similarly to the effect of prp-8
(RNAi), ectopic expression of egl-1::GFP and arrested devel-
opment (Supplemental Fig. S5).
To confirm the impact of DNA dam-
age or replicative stress in the expression
of egl-1 and atl-1, larvae were exposed to
UV or treated with HU, respectively, and
expression levels of these two genes were
studied by qPCR 24 h after L1 (the same
stage at which animals were harvested for
RNA-seq experiments). These two DNA
insults were capable of increasing the ex-
pression levels of atl-1 and egl-1 (Fig.
4C). Interestingly, we observed that the
tissue-specific up-regulation of atl-1
and egl-1 occurred when prp-8(RNAi)
was efficient in the hypodermis but did
not happen when the RNAi worked in
muscle cells only (Fig. 6C).
All together, these results suggest that
larval arrest, cell type-specific apoptosis,
and up-regulation of egl-1 and atl-1 could
be consequences of DNA alterations driv-
en by impaired functions of the spliceo-
some in a particular cell type.
DISCUSSION
Despite the publication of more than two hundred reports
about the implication of spliceosome components in RP,
the molecular mechanisms behind the role of ubiquitous
proteins in a retinal-specific disease are still unclear. Similar-
ly, SMN1 and SMN2 are widely expressed in human tissues
but their mutations only produce defects in motor neurons.
Such neuronal defects cause spinal muscular atrophy, a hu-
man disease that has also been investigated in C. elegans
through the worm ortholog smn-1 (Briese et al. 2009;
Sleigh et al. 2011). This is just one example of the multiple
human diseases (others are cancer or metabolic disorders)
that have been studied and modeled in the multicellular
organism C. elegans (Markaki and Tavernarakis 2010).
Conveniently, s-adRP genes and the mechanisms of splic-
ing in which they are implicated are very well conserved,
which justifies the study of splicing-associated diseases in
worms.
Alterations in U4 or U5 snRNP coding genes have
a different impact on the organism
Based on the analysis of RNAi phenotypes, our study distin-
guishes between s-adRP genes coding for U4 or U5 compo-
nents. All s-adRP proteins are required to activate the
spliceosome, but U5 proteins remain in the activated com-
plex whereas U4 proteins do not. This wider role of U5
snRNPs in splicing could explain why human genes coding
for U5 snRNPs allow less harmful mutations than U4
snRNP coding genes. For example, most PRP8 adRP
FIGURE 3. Intron retention caused by RNAi of s-adRP genes in different backgrounds and stag-
es. Proportion of reads (73 bp) mapping within intron or in the intron–exon border in L3 N2 and
smg-1 mutants or in adult glp-4 mutants, upon the indicated RNAis.
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mutations consist of a single amino acid change, caused by a
point mutation in the last exon (exon 42) (Grainger and
Beggs 2005; Towns et al. 2010), whereas genes coding U4
snRNP components such as PRPF31 include null alleles
that are able to be maintained in heterozygosis in adRP pa-
tients (Mordes et al. 2006; Rio Frio et al. 2008), and probably
somatic loss of heterozygosity (Abu-Safieh et al. 2006).
Accordingly, it is likely that human nonretinal cells can
only handle the loss of a functional copy of the gene in s-
adRP genes coding for U4 snRNPs components such as
PRP31. Because there are still adRP patients whose disease-
causing mutation has not been identified, other genes encod-
ing proteins required for the tri-snRNP U4/U6·U5 forma-
tion, such as SNU114 (U5 snRNP) or SNU13 (U4 snRNP),
are candidates to be screened for mutations responsible of
adRP (de Sousa Dias et al. 2013).
Mutations in the U4 component PRP31 cause adRP with a
variable penetrance that allows some carriers to stay asymp-
tomatic. Recent studies focused on factors influencing the
regulation of PRPF31 expression and therefore the pathogen-
ic effect of these mutations (Venturini et al. 2012; Rose et al.
2014). Our reporter strains carrying both the promoter and
the 3′ UTR of prp-31 can be used as a system to identify genes
or conditions that could influence the expression of prp-31.
Although we did not observe haploinsufficiency in worms
heterozygous for a deletion in prp-31, these animals can serve
as a sensitive background to search for factors capable of in-
fluencing prp-31 functions.
Because all s-adRP proteins function in early splicing steps,
future studies should focus on spliceosome assembly rather
than on intron removal (catalysis) to unmask common
mechanisms of action fueling the pathology.
Worms as a model for s-adRP
This study proposes the usage of C. elegans as a model to in-
vestigate the cellular mechanisms causing a subtype of the
rare disease RP. Such a proposal is strongly supported by
the following arguments: (i) Through RNAi we can mimic
the partial loss of function of s-adRP genes occurring in RP
patients (Longman et al. 2000). (ii) RNAi of s-adRP genes
causes mild intron retention similar to what has been
observed in other s-adRP models (Gamundi et al. 2008;
Tanackovic et al. 2011b). (iii) Some retina cells of s-adRP
patients suffer apoptotic cell death, whereas cells in other tis-
sues are unaffected, and our model induces the ectopic ex-
pression of the pro-apoptotic gene egl-1 and the onset of
apoptotic cell corpses in developing hypodermal cells. (iv)
RNAi by feeding of s-adRP genes supposes a constraint to
developmental processes requiring high transcriptional activ-
ity (larval development for U5 genes and germline develop-
ment for U4 genes), and s-adRP patients present disease
only in the retina, a human tissue with very high transcrip-
tional requirements (Derlig et al. 2015), whereas other tissues
are asymptomatic.
FIGURE 4. Up-regulation of atl-1 and egl-1 after RNAi of s-adRP genes
follows a gradient from prp-8(RNAi) to prp-31(RNAi). (A) RNA-seq
data of atl-1 and egl-1 after RNAi in wild-type worms. FPKM represents
the fragments per kilobase of transcript per million mapped reads. Bars
indicate the average “confidence_high” and “confidence_low” values
provided by Cufflinks (Trapnell et al. 2012) for each gene. (B)
Validation of the RNA-seq data by qPCR. mRNA levels of atl-1 and
egl-1 upon RNAi of some s-adRP genes are represented relative to their
expression in gfp(RNAi) control animals (arbitrary value of 1, indicated
with a gray line). qPCR expression data were normalized to transcript
levels of tbb-2. Three separate experiments were analyzed. Error bars
represent the standard deviation. Student’s t-test for independent sam-
ples was used to analyze the statistical significance: One, two, and three
asterisks indicate P < 0.05, P < 0.01, and P < 0.001, respectively. (C)
Both DNA insults, UV and hydroxyurea, produce an increase in atl-1
and egl-1 expression. Quantification of expression levels of atl-1 and
egl-1 in wild-type animals treated either with UV (100 J/m2) or hydroxy-
urea (25 mM). Expression levels of these genes are represented relative
to the ones in untreated worms.
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Why do mutations in s-adRP genes have the ability
to cause retina-specific diseases in humans?
Several hypotheses have been formulated to address this
question and probably most of them are valid considering
the complexity of the retina and the diversity of mutations
leading to s-adRP. Taking into consideration the published
data and our study, we find three compatible possibilities,
which are defects in splicing reactions, lower transcriptional
efficiency, and genome instability through the formation of
R-loops (Fig. 8).
The most straightforward explanation is that splicing is in-
efficient in the retina, where cells present a high transcrip-
tional activity, causing a reduction in the mRNA
production and consequently a deficit in the amount of pro-
teins. However, these defects in constitutive splicing are not
general because studies in lymphoblastoid cell lines from s-
adRP patients demonstrates that only five out of 57 introns
tested presented unspliced products
(Tanackovic et al. 2011b). Moreover,
only three of these five intron retention
events were common for all the PRPF
mutations tested (Tanackovic et al.
2011a,b). Nevertheless, although a limit-
ed/mild intron retention has been ob-
served in s-adRP models (Wilkie et al.
2008; Tanackovic et al. 2011b), a correla-
tion between slight intron retention in
certain genes and retinal degeneration
has not been clearly established yet
(Mordes et al. 2006).
In C. elegans, by RT-PCR and by
observing intron retention events in a
genome browser (i.e., a fmo-5 intron
[Supplemental Fig. S3]), we conclude
that the likelihood of a partial depletion
of s-adRP genes keeping transcripts
unspliced is low, underscoring a high
buffering capacity of spliceosomal pro-
teins to maintain their essential functions
despite an important reduction of their
activity.
The alteration of these adRP splicing
components may affect alternative splic-
ing (AS) and thus the balance among iso-
forms. In fact, it has been shown that AS
is affected in cell lines derived from pa-
tients carrying s-adRP mutations
(Tanackovic et al. 2011b). The alterations
in the levels of alternative transcripts do
not seem to be similar in cell lines with
different s-adRP mutations (Tanackovic
et al. 2011b). On the contrary, a recent
report based on siRNA in cell lines has
uncovered a link between patterns of AS
alterations and functionally related spliceosome components
(Papasaikas et al. 2014). To explore the effect of our RNAi as-
says on AS we checked a panel of eight AS events occurring
at L2 and L3 larval stages (Ramani et al. 2011) and did not
find common AS alterations in s-adRP RNAi samples
(Supplemental Table S3).
In any case, it is difficult to justify C. elegans’ phenotypes,
as well as the retinal degeneration in humans, just by slight
intron retention or by a modest unbalance of alternative tran-
scripts, which argues in favor of a more complex mechanism.
The second possible answer relies on co-transcriptional
splicing. It is well established that splicing and transcription
are coordinated processes and that alterations in the spliceo-
some can affect the transcriptional machinery (Das et al.
2007; Fong et al. 2013; Fontrodona et al. 2013; Montecucco
and Biamonti 2013). As an example of such co-transcription-
al splicing in a developing multicellular animal, our laborato-
ry demonstrated that RSR-2 interacts with PRP-8 and the
FIGURE 5. egl-1::GFP expression is ectopically induced in prp-8(RNAi) animals. Expression of
the transgene opIs56 [Pegl-1::2xNLS::GFP] after 24 h at 20°C in (A) control RNAi (empty vector)
and (B) prp-8(RNAi). Size of the animals and the germline development stage indicate that in our
experimental conditions prp-8(RNAi) worms develop to a similar stage as N2 during the first 24
h. prp-8(RNAi) worms ectopically express GFP in additional cells, including hypodermal seam
cells (magnified area). Blue fluorescence is shown to label areas with autofluorescence. Images
displayed are representative of three different experimental replicates. (C,D) Animals treated
with prp-8(RNAi) display additional apoptotic cell corpses. The ced-6 mutant larvae treated
with (C) control RNAi and (D) prp-8(RNAi). Black arrows indicate apoptotic cells (button-
like refractile corpses) that were found in prp-8(RNAi) worms but not in control animals. The
right panel shows a magnified image of the area highlighted with a white box.
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RNA polymerase II (RNAPII) in C. elegans, and that the im-
pairment of RSR-2 functions results in a lower transcription-
al efficiency (Fontrodona et al. 2013). Consistent with this
second hypothesis, the mutant allele prp-8(rr40), which re-
duces the levels of wild-type PRP-8, diminishes the produc-
tion of highly expressed germline transcripts, but it does not
affect the splicing reaction (Hebeisen et al. 2008).
Finally, our results support a third hypothesis that can co-
exist with the previous ones: A reduction in the activity of s-
adRP proteins produces genomic instability that, in cells with
high transcriptional activity, can contribute to programmed
cell death. The impairment of the splicing machinery can
form R-loops (RNA/DNA duplex) that expose the single-
strand DNA (ssDNA) to DNA-damaging agents such as
UV light at active transcriptional regions (Aguilera and
García-Muse 2012, 2013). This would explain the sensitivity
of prp-8(RNAi) animals to UV exposure. Moreover, R-loops
are also a source of transcriptional associated mutagenesis
(TAM), which is elevated under high transcriptional activity
(Kim et al. 2007) and can induce apopto-
sis (Hendriks et al. 2010).
In addition to the formation of these
DNA damage-prone sites, R-loops can
contribute to genome instability because
replication and transcriptional machin-
eries could meet and collide at these R-
loop sites leading to replicative stress
(Brambati et al. 2015). In C. elegans the
collision with the replication machinery
is feasible because hypodermal cells are
actively dividing during larval stages
and also suffer a round of endoreplica-
tion (Sulston and Horvitz 1977; Hedge-
cock and White 1985). In mammalian
cells, the existence of a proliferative ca-
pacity in adult retinal cells has been re-
ported (Tropepe et al. 2000; Kiilgaard
et al. 2007; Al-Hussaini et al. 2008), pro-
viding a possible scenario for replicative
stress in dividing cells.
However, in the process of under-
standing the pathogenesis of the disease,
we should take into consideration that
the retinal degeneration of adRP patients
is a gradual process that may take many
years. Here we present C. elegans as a
promising model to investigate mecha-
nisms of the disease and potential thera-
pies in a short time frame.
Future prospects
In this study, we present a robust model
to study s-adRP in C. elegans. We focused
our attention in atl-1 and egl-1, but we
have identified other interesting genes in our data set (which
is available at the Gene Expression Omnibus [GEO] reposito-
ry) that are up-regulated in animals with reduced levels of
spliceosomal proteins and thatmay have a role in compensat-
ing or repairing such deficiency. Among them, we identified
genes coding for spliceosome components such as mog-4,
mog-5, prpf-4, or ddx-23 (Supplemental Table S1; Kerins
et al. 2010).
Through an increased sensitivity to DNA insults and rep-
licative stress we have opened a third way to explain the ret-
ina-specific apoptosis in s-adRP. This alternative way should
be explored in terms of therapies that could alleviate the pro-
gressive loss of vision in s-adRP patients. To such aim, C. ele-
gans can play a key role thanks to its amenability for high-
throughput screening.
Our approach takes advantage of the RNAi but the new
technologies for genome editing and the functional conserva-
tion of spliceosomal genes are making feasible the introduc-
tion of human s-adRP mutations in worms (Waaijers and
FIGURE 6. prp-8(RNAi) animals display tissue-specific phenotype. (A) Larval arrest phenotype
was observed in wild-type- and hypodermis-specific RNAi animals (rde-1 (ne219) V; KzIs9), while
no obvious phenotype was observed in muscle-specific RNAi worms (rde-1 (ne219) V; KzIs20).
Representative images were taken under the stereoscope after 48 h at 20°C. Scale bar, 1 mm. (B)
Body length measure of wild-type, and hypodermis- and muscle-specific RNAi animals fed
with prp-8(RNAi) and control (empty vector) clones. Animals synchronized at L1 stagewere treat-
ed with the corresponding RNAi clone and grown at 20°C. More than 25 worms were measured
after 48 h of treatment in each condition. Animal length is showed in millimeters and was scored
using the ImageJ software. Statistical significance was calculated using Student’s t-test for indepen-
dent samples. Three asterisks indicate statistical significance with P < 0.001.Whiskers were plotted
by Tukey’s test. (C) Up-regulation of atl-1 and egl-1 after prp-8(RNAi) is tissue specific. qPCR re-
sults for atl-1 and egl-1 expression in wild-type and hypodermis- and muscle-specific RNAi ani-
mals represented in a bar graph. mRNA levels of these genes after prp-8(RNAi) are relative to
their expression in control animals. Results obtained from three independent biological replicates.
mRNA transcript levels of atl-1 and egl-1 are normalized against tbb-2 levels and represented in a
log10 scale in both experiments. Error bars represent standard deviation.
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Boxem 2014). This approach could be an ideal platform to
develop personalized medicine and drug discovery.
MATERIALS AND METHODS
Strains
Standard methods were used to culture and manipulate worms
(Stiernagle 2006; Porta-de-la-Riva et al. 2012). In this study,
we used the wild-type Bristol N2 and the strains TR1331: smg-1
(r861) I, SS104: glp-4(bn2) I, CER87: unc-119(ed3) III, cerEx79
[Pprp-31::GFP::H2B::prp-31 3′ UTR + pGH8 + unc-119(+)],
CER148: unc-119(ed3) III; cerIs05[Pprp-31::GFP::H2B::prp-31
3′ UTR +unc-119(+)], CER149: unc-119(ed3) III; cerIs06[Pprp-
31::GFP::H2B::prp-31 3′ UTR +unc-119(+)], VC2709: prp-31
(gk1094) I/hT2[bli-4(e937) let-?(q782) qIs48](I;III), CER100: prp-
31(gk1094)/unc-57(ad592) dpy-5(e61) I, CER101: +/unc-57
(ad592) dpy-5(e61) I, VC3460: prp-8(gk3511) III/hT2 [bli-4(e937)
let-?(q782) qIs48] (I;III), BC12486: dpy-5(e907) I; sEx12486[Pprp-
8::GFP + pCeh361], WS1973: unc-119(ed3) III; opIs56[Pegl-
1::2xNLS::GFP + unc-119(+)], MT4970: ced-6(n2095) III, NR222:
rde-1(ne219) V; kzIs9[pKK1260(lin-26p::nls::GFP) + pKK1253(lin-
26p::rde-1) + pRF6(rol-6(su1006)], NR350:
rde-1(ne219) V;kzIs20[pDM#715(hlh-1p::rde-




To induce RNA-mediated interference
(RNAi) by feeding, nematode growth medi-
um (NGM) plates were supplemented with
50 µg/mL ampicillin, 12.5 µg/mL tetracycline,
and 1 mM IPTG. NGM-supplemented plates
were seeded with the corresponding RNAi
clone. All RNAi clones but the one corre-
sponding to snrp-200 were obtained either
from the ORFeome library (Rual et al. 2004)
or the Ahringer library (Kamath et al. 2003).
From cDNA we generated an RNAi clone
(pCUC24) for snrp-200 by Gateway cloning
(amplicon size 1091 bp), which includes the
spliced sequence from 106 to 1197 bp (prim-
ers available under request). Each clone was
validated by PCR and/or sequencing. To study
the RNAi phenotypes of s-adRP genes, a syn-
chronized population of N2 worms at L1 stage
was fed with each clone and grown at 20°C. To
induce RNAi by microinjection, dsRNA was
synthesized from the RNAi feeding clone by
using MEGAscript T7 kit (Ambion). Wild-
type young adults were injected with 1 μg/μL
of dsRNA.
RNA sequencing
RNA-seq analyses were performed using RNA
of the following population sets: synchronized
N2 and smg-1(r861) L1 larvae fed for 24 h at 20°C with the RNAi
clones of prp-6, prp-8, prp-31, and gfp; and 5-d adult glp-4(bn2)
worms grown at 25°C and fed first, for 72 h with OP50 and next,
for 48 more hours with the RNAi clones of prp-8, prp-31, and gfp.
RNA was isolated with TRI Reagent (MRC, Inc.) and purified
by using the Purelink RNA Mini kit (Ambion) and Purelink
DNAse (Ambion). RNA samples were subjected to quality and
yield controls on the Agilent 2010 Bioanalyzer and Nanodrop
Spectrophotometer, respectively. Poly(A)-enriched samples were
multiplexed in libraries for paired-end RNA sequencing on
Illumina Hiseq 2000 platform, through the CNAG (Centro
Nacional de Análisis Genómico) sequencing facility. To generate
BAM files, more than 50 million reads (length of 73 bp) for sample
were mapped against the C. elegans worm version WS236 following
the GEMTools pipeline (http://gemtools.github.io/). These BAM fi-
les were analyzed using the SeqSolve software, which use Cufflinks/
Cuffdiff for differential gene/transcript expression analyses
(Trapnell et al. 2012). A full 98.7% of the reads from the control
gfp(RNAi) sample mapped in exons. The sequence data for the 11
transcriptomes analyzed in this study are available at the NCBI
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) un-
der accession number GSE72952.
FIGURE 7. Higher sensitivity to UV damage observed in prp-8(RNAi)-treated animals. After UV
exposure, foci formation evidenced by the transgene opIs263 [Prpa-1::rpa-1::YFP+unc-119(+)] is
more abundant in animals with partial inactivation of prp-8 compared with control worms (fed
with empty vector clone). (A) Representative confocal images of transgenic worms carrying the
RPA-1::YFP transgene under control and prp-8(RNAi) conditions. RNAi treatment started
from L1 stage at 20°C. After 24 h, animals were exposed to a 100 J/m2 dose of UV-C radiation,
and 24 h later foci formation was assessed through confocal microscopy. Foci formation was ob-
served in somatic and germline cells in both conditions. White squares showmagnified images of
germline cells with RPA-1::YFP foci. (B) Quantification of foci formation per cell represented in a
dispersion graph. Each square (control) and dot (prp-8(RNAi)) represents the number of cells
displaying the corresponding amount of foci. Only somatic and germline cells that displayed
one or more foci were scored.
Rubio-Peña et al.
2128 RNA, Vol. 21, No. 12
Real-time PCR
For gene expression analyses, synchronized worms were harvested,
washed, and frozen in TRI Reagent to perform total RNA isolation.
cDNA was synthesized with oligo(dT) primers using the RevertAid
HMinus First Strand cDNA synthesis kit (ThermoScientific) follow-
ing the manufacturer’s instructions. To determine gene expression,
the LightCycler 480 SYBR Green I Master kit (Roche) was used.
Generation of transgenic reporter strains
The molecular construct to study the expression and localization of
prp-31 (pCUC32) was made by the Gateway recombination cloning
system (Invitrogen). The 5′ entry clone includes 664 bp of the pro-
moter region, and 3′ entry clone contains the 77 bp of the 3′ UTR
sequence (primer sequences available upon request). Plasmid
pCM1.35 was used as the middle entry clone and pCFJ150 was
the destination vector.
Microinjection
Transgenic animals were generated by microinjecting 2 ng/µL of
pCUC32 [Pprp-31::GFP::H2B::prp-31 3′ UTR +unc-119(+)] togeth-
er with 20 ng/µL of the red neuronal marker pGH8 [Prab-3::
mCherry::unc-54utr] into DP38 [unc-119(ed3)] young adult worms.
78 ng/µL of 1 Kb Plus DNA ladder (Invitrogen) were used as carrier.
Wild-type animals were selected over uncoordinated (Unc) worms,
and mCherry expression was checked under the dissecting micro-
scope. GFP expression was observed at high magnification using
an inverted fluorescence Nikon ECLIPSE Ti-S microscope.
Bombardment
One and a half milligrams of gold powder (Chempur, gold powder
0.3–3.0 micron 99.9%) was transferred to a low protein binding
1.5-mL tube, resuspended in 150 µL of 50mM spermidine, and son-
icated for 10 sec.Twenty-fourmicrogramsof pCUC32DNAwasadd-
ed to the mixture, deionized water was added up to 540 µL, and the
mixture was incubated for 10 min. Next, we added 150 µL of 1 M
CaCl2. The mixture was incubated for another 10 min and centri-
fuged atmaximumspeed for 30 sec. After threewasheswith 96%eth-
anol, the pellet was resuspended in 300 µL PVP 0.1 mg/mL in EtOH.
Shots with 20 µL of the suspension were performed using a Caenotec
gene gun on pre-chilled 35-mm plates with 20–30 µL of DP38 [unc-
119(ed3)] young adults. Then the NGM agar of each plate was sliced
into six pieces, and each slice was placed on a 90-mm plate. These
plates were incubated at 20°C for 2 wk and then screened for trans-
genic worms that rescued the unc-119(ed3) phenotype.
Replicative stress induction
To induce replicative stress we used hydroxyurea (HU) (Sigma-
Aldrich, Cat# H8627). In all cases 25 mM HU plates were used
and prepared adding 500 µL of 0.5 M HU to plates containing
10 mL of NGM medium and seeded with E. coli OP50. To observe
egl-1 expression, synchronized Pegl-1::GFP (WS1973) L1 worms
were grown in either HU or standard plates for 24 and 48 h at
20°C. After each time point, worms were recovered with M9 buffer,
washed, and mounted using 0.3 mM of levamisole for in vivo obser-
vation through an inverted fluorescence microscope. To quantify
the expression levels of atl-1 and egl-1 in a replicative stress context,
synchronized N2 L1 worms were grown at 20°C for 24 h in HU
plates and then recovered with M9 buffer for total RNA isolation.
DNA damage induction through UV-C exposure
Synchronized worms were exposed to UV-C light (254 nm) at dif-
ferent time points depending on the experiment. A UV crosslinker
(model 2400, Stratagene) was used to apply 100 J/m2 in all the cases.
Before the exposure to UV-C, worms were washed several times to
get rid of bacteria and placed in a bacteria-free NGM plate.
To quantify the expression levels of atl-1 and egl-1 upon DNA
damage induced by UV-C exposure, synchronized L1 N2 worms
were grown in standard conditions at 20°C. UV-C exposure was per-
formed 18 h post L1 and total RNA isolation 6 h later.
Foci quantification
For RPA-1 foci observation synchronized Prpa::YFP L1 worms were
grown at 20°C for 24 h. Then, they were exposed to UV-C and later
FIGURE 8. Model for the tissue-specific apoptosis in s-adRP. (A)
Similarly to humans, s-adRP genes are expressed in all C. elegans cell
types. Partial inactivation of s-adRP genes causes tissue-specific defects
both in humans and worms. (B) In normal condition, splicing occurs
cotranscriptionally. (C) When the functioning of the splicesome is al-
tered, the activity of the RNAPII is affected and R-loops (DNA–RNA hy-
brids) are produced, creating single-strand DNA regions that are more
sensitive to DNA insults. Moreover, R-loops may cause collisions be-
tween the transcriptional and the replicative machineries.
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placed again in control or prp-8(RNAi) plates for an additional 24
h. Worms were then mounted using 0.3 mM of levamisole and ob-
served using a confocal fluorescence microscope. RPA-1::YFP foci
formation was quantified by counting the number of bright foci pre-
sent in germline and somatic cells.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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